Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ACV Auctions has delivered one of the more striking moves in its peer group this past month, and the question heading into November earnings is whether the positioning data supports or challenges that run.
The stock closed at $10.44 on October 7, barely changed on the week but up roughly 50% over the past month. That kind of move compresses the gap between price and analyst targets fast. The Street's mean price target sits at $10.10, implying a fractional downside from current levels. That's not a valuation that screams conviction from either direction, and the analyst flow over the past several weeks has been largely cautious. After the August earnings print, Barclays downgraded to Underweight with a $6.00 target, a stark contrast to where the stock eventually landed. Needham cut from Buy to Hold in September. Barrington Research moved to Underperform. CJS Securities downgraded to Market Perform. The most constructive recent action came from Citigroup, which lifted its Neutral target to $10.50 in mid-September, essentially flagging that the stock had repriced to fair value rather than offering upside. With two buys, six holds and notable sell-side caution in the mix, the consensus rating is Hold, and the cluster of downgrades through August and September tells its own story about how the Street views the month's re-rating.
Short positioning adds an interesting counterpoint. Bears have been backing away through October. Short interest as a percentage of the free float has dropped to 7.8%, down from a peak closer to 9.5% in mid-September when the stock was trading at lower levels. The one-month decline in shares short is over 8%. That retreat coincides almost exactly with the stock's surge, which suggests at least part of the move has been short covering rather than fresh long conviction. The lending market has followed suit: availability has exploded to over 6,000% of short interest, meaning there are roughly 91.6 million shares available to borrow against 13.4 million currently shorted. Borrowing costs have collapsed in parallel, from around 0.65% a month ago to just 0.06% on the latest reading, an 88% weekly drop. None of this signals squeeze pressure; it signals that the short thesis has softened and the borrow market is wide open for anyone who wants to re-establish a position.
The ORTEX short score has also moved in the same direction, falling from around 50 in early October to 42.7 now. A score below 50 generally reflects relatively benign short-side conditions, though it's worth noting that the score was above 45 as recently as last week. Factor scores paint a mixed picture. Forward earnings momentum ranks in the 98th percentile, an extraordinary reading driven by sharp upward revisions to the 12-month forward estimate. EPS surprise, however, ranks just 7th percentile, meaning the company has a history of missing on the bottom line. The short score ranks 22nd percentile and the utilization rank sits at 41st percentile, both consistent with the loose borrow conditions described above. Options positioning is mildly more hedged than usual: the put/call ratio at 0.47 is above its 20-day mean of 0.41, but only by about 0.6 standard deviations, well within normal range and nowhere near the 52-week high of 0.59.
One ownership footnote worth noting. Brown Advisory entered the top-holder list with 6.9 million shares, a position that appears to be a new build or near-new given the 6.87 million last-change figure. BlackRock added nearly 940,000 shares in the period to September 30, now holding 8.3% of shares. These are passive and semi-active flows rather than activist moves, but the building on both sides of the institutional ledger, alongside the short covering, partly explains why the stock found a bid. On the activist register, all filings are 13G (passive), and there is no 13D activist on the schedule. Gavin Baker, the highest-profile individual filer, nudged his disclosed stake slightly higher to 5.7% as of August. These are as-last-disclosed positions around the 5% threshold; holders can exit below that level without a further filing.
Insider activity in early October was entirely tax-withholding transactions (SEC code F) from the CFO and Chief Sales Officer. These are compensation mechanics, not discretionary trades, and carry no directional signal.
The next earnings print is scheduled for November 4. The most recent comparable report, in August, saw the stock fall 2.7% on the day before recovering to a modest five-day gain. The prior print in May produced a 6.9% one-day drop with a continued decline over five days. With the stock now trading at or just above the mean analyst target after a 50% monthly move, the November print carries higher-than-usual stakes: whether the forward earnings revision that's driving the 98th-percentile momentum score starts translating into actual beats will be the central question of the quarter.
See the live data behind this article on ORTEX.
Open ACVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
